BRIEF published on 11/14/2024 at 07:35, 7 days 4 hours ago PharmaSGP prévoit une forte croissance de son chiffre d'affaires au cours des 9 premiers mois de 2024 et relève ses prévisions pour l'ensemble de l'année Croissance Des Revenus Stratégie De Marché PharmaSGP Produits Pharmaceutiques En Vente Libre Prévisions Pour 2024
BRIEF published on 11/14/2024 at 07:35, 7 days 4 hours ago PharmaSGP Sees Strong Revenue Growth in 9M 2024, Raises Full-Year Forecast Revenue Growth Market Strategy 2024 Forecast PharmaSGP OTC Pharmaceuticals
PRESS RELEASE published on 11/14/2024 at 07:30, 7 days 4 hours ago PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised PharmaSGP Holding SE reports strong revenue growth in 9 months of 2024, with preliminary figures showing a 17.0% increase compared to the same period last year. FY 2024 revenue forecast raised Financial Results Revenue Growth Pharmaceuticals Forecast PharmaSGP
BRIEF published on 11/05/2024 at 10:12, 16 days 1 hour ago Leadership Transition at PharmaSGP Holding SE: Peter Gerckens to Succeed Natalie Weigand as CEO Company Growth OTC Pharmaceuticals Peter Gerckens Natalie Weigand PharmaSGP Leadership Change
BRIEF published on 11/05/2024 at 10:12, 16 days 1 hour ago Transition de direction chez PharmaSGP Holding SE : Peter Gerckens succède à Natalie Weigand au poste de PDG Croissance De L'entreprise Produits Pharmaceutiques En Vente Libre Pierre Gerckens Nathalie Weigand Changement De Direction Chez PharmaSGP
PRESS RELEASE published on 11/05/2024 at 10:07, 16 days 1 hour ago CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 PharmaSGP Holding SE announces CEO change with Peter Gerckens succeeding Natalie Weigand on January 1, 2025. Smooth transition planned for internal succession Succession Plan CEO Change PharmaSGP Holding SE Peter Gerckens Natalie Weigand
BRIEF published on 11/05/2024 at 10:07, 16 days 1 hour ago Leadership Change at PharmaSGP Holding SE: Peter Gerckens Appointed CEO Leadership Transition CEO Change PharmaSGP Holding SE Peter Gerckens Natalie Weigand
BRIEF published on 11/05/2024 at 10:07, 16 days 1 hour ago Changement de direction chez PharmaSGP Holding SE : Peter Gerckens nommé PDG Transition De Direction Changement De PDG PharmaSGP Holding SE Pierre Gerckens Nathalie Weigand
PRESS RELEASE published on 11/05/2024 at 10:02, 16 days 1 hour ago EQS-Adhoc: PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer PharmaSGP Holding SE appoints Peter Gerckens as new CEO, succeeding Natalie Weigand. Gerckens, currently CCO, will assume the CEO position on January 1, 2025 Supervisory Board PharmaSGP Holding SE CEO Succession Peter Gerckens Natalie Weigand
BRIEF published on 10/01/2024 at 08:20, 1 month 20 days ago PharmaSGP Holding SE acquiert 477 701 actions par le biais d'une offre de rachat Actions Propres Rachat D'actions Réduction De Capital Offre De Rachat PharmaSGP
Published on 11/21/2024 at 11:30, 16 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 1 hour 43 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 46 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 46 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 11 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 11:30, 16 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 45 minutes ago Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 46 minutes ago First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 49 minutes ago ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 16 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 06:58, 4 hours 48 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 48 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 48 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 39 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 26 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
